COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

Dr. Tatiana Cohen

Dr. Tatiana Cohen

Scientific Review Officer



Biography

Division:
Division of Basic and Integrative Biological Sciences DBIB
IRG:
Interdisciplinary Molecular Sciences and Training IMST
Study Section:
Cellular and Molecular Technologies CMT

Dr. Tatiana Cohen obtained her Ph.D. in pharmacology at the University of Maryland at Baltimore, where she studied transcriptional regulation of muscle-specific genes.

She continued her postdoctoral training at the National Cancer Institute, where she developed transgenic mouse models of human disorders that result from mutations in nuclear envelope-associated proteins. She then joined the Children’s Research Institute, where she used gene microarrays and proteomic profiling and developed cell-based assays for modeling mechanisms of gene expression underlying muscle disease. Prior to joining CSR, Dr. Cohen was faculty at the Kennedy Krieger Institute with a dual appointment in the Department of Neurology at the Johns Hopkins University.